Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Avvisati

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Blood Cancer Journal|July 26, 2012
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric studyA Andriani, M T Petrucci, T Caravita, et al.
British Journal of Haematology|September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 casesC Guglielmi, M P Martelli, D Diverio, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Leukemia|April 29, 1998
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phaseD Russo, M Regazzi, S Sacchi, et al.
Clinical Drug Investigation|March 29, 2008
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week OffM B Regazzi, D Russo, I Iacona, et al.
Journal of the National Cancer Institute|February 5, 1998
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cellsW Shao, M Fanelli, F F Ferrara, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant networkF Marchesi, A Mengarelli, F Giannotti, et al.
British Journal of Haematology|February 28, 2001
Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemiaL Pagana, A Pulsoni, M E Tosti, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Blood Cancer Journal|July 26, 2012
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric studyA Andriani, M T Petrucci, T Caravita, et al.
British Journal of Haematology|September 12, 1998
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 casesC Guglielmi, M P Martelli, D Diverio, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Leukemia|April 29, 1998
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phaseD Russo, M Regazzi, S Sacchi, et al.
Clinical Drug Investigation|March 29, 2008
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week OffM B Regazzi, D Russo, I Iacona, et al.
Journal of the National Cancer Institute|February 5, 1998
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cellsW Shao, M Fanelli, F F Ferrara, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant networkF Marchesi, A Mengarelli, F Giannotti, et al.
British Journal of Haematology|February 28, 2001
Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemiaL Pagana, A Pulsoni, M E Tosti, et al.
Pageof 15